RI-MUHC trainee honoured by the American Association for Cancer Research
Yasmine Benslimane is investigating how the female hormone estrogen influences the spread of colon cancer...
Fall 2021 CIHR competition results
RI-MUHC teams received $9.5 million in project funding
Three renewed Canada Research Chairs for RI-MUHC researchers
Ahmad Haidar, Dennis Jensen and Ian Watson are part of the McGill University cohort of 17 new and renewed Canada Research Chairs
Dr. Tarek Hijal appointed Chair of the National Radiation Oncology Committee
The MUHC is proud and pleased to announce that the Programme québécois de cancérologie (PQC) of...
RI-MUHC researchers led one of Québec Science magazine’s top 10 discoveries of the year
Jean-Jacques Lebrun and his team have discovered a promising treatment for triple negative breast cancer
$2M to the MUHC Foundation for precision cancer care
BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program
RI-MUHC research team leads new consortium to make healthcare data more accessible
The new Quebec SmartCare Consortium has received $10M to break down data silos and increase the...
FANCI: a new gene at the origin of some cases of ovarian cancer
For the first time, researchers link mutations in the FANCI gene to the risk of developing ovarian cancer
RI-MUHC trainee Prisca Bustamante honoured by Mitacs Award for Outstanding Innovation
Doctoral student develops world's first non-invasive blood screening test for uveal melanoma
RI-MUHC study shows impact of combinatorial immunotherapy on an aggressive cancer
A combinatorial immunotherapy may provide significant therapeutic benefit in managing pancreatic ductal...